EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, NTRA: Natera Inc

16 Dec 25 16:56
LAST:

227.4

CHANGE:
 1.00		OPEN:
227.8		HIGH:
229.2		ASK:
10.9		VOLUME:
867.8K
CHG(%):
0.44		PREV:
228.4		LOW:
225.8		BID:
8.2		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Dec 25227.8229.2225.8227.4898.2K
15 Dec 25229.3232.8227.0228.41.14M
12 Dec 25231.5232.2225.6232.01.36M
11 Dec 25230.0234.8227.4231.11.12M
10 Dec 25235.6239.2231.7233.11.3M
09 Dec 25239.5241.5234.1235.51.08M
08 Dec 25245.3246.9238.1239.11.4M
05 Dec 25242.2245.6239.0244.61.37M
04 Dec 25239.1243.7237.9242.11.23M
03 Dec 25237.8239.2234.6238.21.58M

PROFILE

Name:Natera Inc
About:Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera molecular residual disease test for assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based genomic profiling test, that provides insight into genomic alterations and biomarkers; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices, research laboratories, and pharmaceutical companies through its direct sales force, and a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
Sector:Healthcare
Address:13011 McCallen Pass, Austin, TX, United States, 78753
Website:https://www.natera.com
CUSIP:632307104
CIK:0001604821
ISIN:US6323071042
FIGI:BBG001J1BQ86

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-129.56 
Forward P/E:-163.67 
PEG Ratio:-0.88 
Price to Sales:13.84 
Price to Book:21.73 
Profit Margin:-0.13 
Operating Margin:-0.20 
Return on Assets:-0.11 
Return on Equity:-0.24 
EPS Ratio:-1.91 
Revenue:1.964B 
Shares:137.25M 
Market Cap:31.21B 

TECHNICAL INDICATORS

MA5:230.391.3%
MA10:235.143.4%
MA20:233.072.5%
MA50:207.559.6%
MA100:184.3823.3%
MA200:168.8934.6%
RSI14:37.42 
WPR14:-100.00 
MTM14:-9.72
ROC14:-0.04 
ATR:6.01 
Week High:241.456.2%
Week Low:225.580.8%
Month High:246.908.6%
Month Low:203.0034.6%
Year High:246.908.6%
Year Low:125.3881.4%
Volatility:13.76